GLAXOSMITHKLINE FDA Approval ANDA 062241

ANDA 062241

GLAXOSMITHKLINE

FDA Drug Application

Application #062241

Application Sponsors

ANDA 062241GLAXOSMITHKLINE

Marketing Status

Discontinued001
Discontinued002

Application Products

001CAPSULE;ORALEQ 250MG BASE0BACTOCILLOXACILLIN SODIUM
002CAPSULE;ORALEQ 500MG BASE0BACTOCILLOXACILLIN SODIUM

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62241
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"BACTOCILL","activeIngredients":"OXACILLIN SODIUM","strength":"EQ 250MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"BACTOCILL","activeIngredients":"OXACILLIN SODIUM","strength":"EQ 500MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"BACTOCILL","submission":"OXACILLIN SODIUM","actionType":"EQ 250MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"BACTOCILL","submission":"OXACILLIN SODIUM","actionType":"EQ 500MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.